RICC A/S: Financial statements 2022
CVR: 20690003
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
RICC A/S (CVR 20690003) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 210,237,000 and a net result of DKK 9,339,000 compared with DKK 4,549,000 the year before. That is an increase of 57.2% compared with the year before. Equity in the 2022 report amounted to DKK 4,456,000. The solvency ratio was 2.5%. The company had 57 employees in the financial year.
- Gross Profit
- DKK 210,237,000
- Profit/Loss
- DKK 9,339,000
- Equity
- DKK 4,456,000
- Total Assets
- DKK 176,186,000
- Employees
- 57
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 210.2 mio. | 9.3 mio. | 4.5 mio. | 57 |
| 2021 | - | 133.7 mio. | 4.5 mio. | -4.9 mio. | 70 |
| 2020 | - | 274.3 mio. | -155.8 mio. | -6 mio. | 63 |
| 2019 | - | 141.4 mio. | 45.9 mio. | 209.8 mio. | 65 |
| 2018 | 198.6 mio. | 159.3 mio. | 914 t. | 107 mio. | 74 |
Official annual report
Keep an eye on RICC A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of November 1, 2022, Isabel Marianne Joerin has joined the board of directors of RICC A/S.
As of November 1, 2022, Beat Christoph Krähenmann has left the board of directors of RICC A/S.
RICC A/S has published its annual report for 2021. Gross profit came to DKK 133,722,000, and the net result was DKK 4,549,000.
About RICC A/S
RICC A/S is a Danish company of the type Aktieselskab based in København V, founded in 1998. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ROCHE INNOVATION CENTER COPENHAGEN A/S and SANTARIS PHARMA A/S. The management consists of Carole Hassoun. The board consists of Sylke Pöhling (chair), Carole Hassoun and Isabel Marianne Joerin. The company is owned by F. Hoffmann-La Roche Ltd. The company has 1 employee (2024). In 2025, the company reported a gross profit of DKK 91,000 and a net result of DKK 160,586,000 compared with DKK 730,000 the year before. Equity in the 2025 report amounted to DKK 163,015,000.